» Authors » Karen C Johnson

Karen C Johnson

Explore the profile of Karen C Johnson including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 333
Citations 22815
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Prentice R, Aragaki A, Zheng C, Manson J, Tinker L, Schoeller D, et al.
Am J Clin Nutr . 2025 Mar; PMID: 40088973
Background: Associations of the macronutrient composition of the diet with total energy intake (EI) are uncertain, as are associations of macronutrient composition with self-reported energy underreporting. Objectives: We aim to...
2.
Mozhui K, Starlard-Davenport A, Sun Y, Shadyab A, Casanova R, Thomas F, et al.
medRxiv . 2025 Mar; PMID: 40061325
The pace of aging varies between individuals and is marked by changes in DNA methylation (DNAm) including an increase in randomness or entropy. Here, we computed epigenetic scores of aging...
3.
Derefinko K, Thomas F, Peter S, Murphy J, Witkiewitz K, Cowan R, et al.
Drug Alcohol Depend . 2025 Feb; 268:112584. PMID: 39923335
Background: Buprenorphine-naloxone treatment engagement for those with opioid use disorder (OUD) is very low. The current randomized effectiveness trial piloted two psychosocial interventions developed to increase buprenorphine-naloxone treatment engagement in...
4.
Mielke M, Evans J, Neiberg R, Molina-Henry D, Marcovina S, Johnson K, et al.
JAMA Netw Open . 2025 Feb; 8(2):e2458149. PMID: 39913137
Importance: Blood-based biomarkers (BBMs) are clinically available to aid in the diagnosis of Alzheimer disease (AD) and AD-related dementias (ADRD), but their association with cognition among older adults with specific...
5.
Palmer R, Neiberg R, Beavers K, Kahn S, Houston D, Wagenknecht L, et al.
Obesity (Silver Spring) . 2025 Feb; 33(3):612-620. PMID: 39904719
Objective: The objective of this study was to elucidate associations between adiposity reduction and changes in HbA1c and insulin use among adults with type 2 diabetes and overweight or obesity....
6.
Soliman A, Wactawski-Wende J, Millen A, Gray S, Eaton C, Hovey K, et al.
J Am Geriatr Soc . 2024 Dec; 73(2):411-421. PMID: 39739511
Background: Epidemiological studies have been inconsistent regarding an association between proton pump inhibitor (PPI) use and risk of primary cardiovascular disease (CVD) events. Methods: We studied 85,189 postmenopausal women (mean...
7.
Elam R, Johnson K, Xu H, Isales C, Dong Y, Carbone L
J Clin Endocrinol Metab . 2024 Sep; PMID: 39259653
Context: Persons with type 2 diabetes have increased fracture risk that existing fracture risk assessment tools underestimate. Objective: Identify fracture predictors in persons with type 2 diabetes and overweight or...
8.
Pajewski N, Beddhu S, Bress A, Chang T, Chertow G, Cheung A, et al.
J Am Soc Nephrol . 2024 Jul; 35(12):1737-1745. PMID: 39078712
No abstract available.
9.
Chlebowski R, Aragaki A, Pan K, Luo J, Rohan T, Johnson K, et al.
J Clin Oncol . 2024 Jul; 42(30):3530-3536. PMID: 39028918
JCO We report long-term colorectal cancer findings from the Women's Health Initiative trial where 16,608 postmenopausal women with a uterus were randomly assigned to daily conjugated equine estrogen (CEE) 0.625...
10.
Chlebowski R, Aragaki A, Pan K, Mortimer J, Johnson K, Wactawski-Wende J, et al.
Breast Cancer Res Treat . 2024 Apr; 206(1):177-184. PMID: 38653905
Purpose: In the Women's Health initiative (WHI) randomized clinical trial, conjugated equine estrogen (CEE)-alone significantly reduced breast cancer incidence (P = 0.005). As cohort studies had opposite findings, other randomized...